Advanced Biomed Inc. Common Stock
NASDAQ: ADVB0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Global Select
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- CEO
- Yi Lu
- Employees
- 40
- Headquarters
- New York City, United States
- IPO year
- 2025
- Market cap
- $5.2M
- Website
- https://www.advanbiomed.com
Loading ADVB…
Loading profile data…Frequently asked questions about ADVB
What does Advanced Biomed Inc. Common Stock (ADVB) do?
Advanced Biomed Inc. functions as an investment holding company, primarily dedicated to the research and development of microfluidic biochip technologies. Based in Taiwan, the company leverages these innovations to enhance precision oncology, spanning cancer detection, diagnosis, and treatment. Its diverse product portfolio includes a suite of a...
Where does ADVB trade?
Advanced Biomed Inc. Common Stock (ADVB) trades on the NASDAQ Global Select.
What sector is ADVB in?
Advanced Biomed Inc. Common Stock (ADVB) operates in the Healthcare sector, specifically in the Medical - Diagnostics & Research industry.
Who is the CEO of Advanced Biomed Inc. Common Stock?
Yi Lu is the chief executive officer of Advanced Biomed Inc. Common Stock (ADVB).
Where is Advanced Biomed Inc. Common Stock headquartered?
Advanced Biomed Inc. Common Stock is headquartered in United States.
Does ADVB pay a dividend?
Advanced Biomed Inc. Common Stock (ADVB) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did ADVB go public?
Advanced Biomed Inc. Common Stock (ADVB) completed its initial public offering in 2025.